Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 357,000 | 314,000 | 302,000 | 266,000 | 298,000 |
| Cost of Goods | 67,000 | 83,000 | 52,000 | 44,000 | 48,000 |
| Gross Profit | 293,000 | 230,000 | 250,000 | 221,000 | 250,000 |
| Operating Expenses | 210,000 | 187,000 | 179,000 | 155,000 | 205,000 |
| Operating Income | 81,000 | 43,000 | 72,000 | 66,000 | 46,000 |
| Interest Expense | 6,000 | 12,000 | 15,000 | 12,000 | 12,000 |
| Other Income | 6,000 | 6,000 | 5,000 | 5,000 | 4,000 |
| Pre-tax Income | 81,000 | 37,000 | 62,000 | 59,000 | 38,000 |
| Income Tax | -21,000 | -5,000 | 44,000 | 11,000 | 17,000 |
| Net Income Continuous | 103,000 | 42,000 | 18,000 | 47,000 | 21,000 |
| Net Income | $103,000 | $42,000 | $18,000 | $47,000 | $21,000 |
| EPS Basic Total Ops | 0.81 | 0.34 | 0.15 | 0.38 | 0.16 |
| EPS Basic Continuous Ops | 0.82 | 0.34 | 0.14 | 0.38 | 0.16 |
| EPS Diluted Total Ops | 0.79 | 0.33 | 0.14 | 0.38 | 0.16 |
| EPS Diluted Continuous Ops | 0.80 | 0.33 | 0.14 | 0.38 | 0.16 |
| EPS Diluted Before Non-Recurring Items | 0.82 | 0.72 | 0.51 | 0.41 | 0.32 |
| EBITDA(a) | $85,000 | $49,000 | $76,000 | $72,000 | $54,000 |